{"nct_id":"NCT02258555","title":"Safety, Pharmacodynamics, Pharmacokinetics, and Efficacy of GS-9901 in Adults With Relapsed or Refractory Follicular Lymphoma, Marginal Zone Lymphoma, Chronic Lymphocytic Leukemia, or Small Lymphocytic Lymphoma","status":"TERMINATED","status_verified_date":"2015-10","start_date":"2015-01","start_date_type":null,"primary_completion_date":"2015-08","primary_completion_date_type":"ACTUAL","completion_date":"2015-08","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["GILD"]}